SUBSCRIBE
SUBSCRIBE

Tocilizumab Protects Joints Better than Methotrexate Alone, University of Texas Southwestern Medical Center Study

October 23, 2009 | 
1 min read

MedPage Today -- PHILADELPHIA -- The investigational biologic agent tocilizumab appeared to prevent joint erosion among rheumatoid arthritis patients better than treatment with methotrexate alone, researchers said here.